Archives

img-01

Korea: Multinational Device Clinical Trial Approved

The Korea Food and Drug Administration (KFDA) recently approved the first multinational clinical trial for a medical device. The device, the Nobori drug-eluting stent, is manufactured by the Terumo Corporation, an international medical device company headquartered in Tokyo, Japan. The trial involves... Read More

img-01

China: Update on Drug Counterfeiting

Although China is making efforts to improve piracy and counterfeit drug enforcement mechanisms, pharmaceutical companies must still be extremely careful in the Chinese market. In fact, currently several large US pharmaceutical companies are facing significant challenges dealing with counterfeit drugs in China.... Read More

img-01

China’s OTC Drug Market Shows Potential Growth

While both the U.S. and European over-the-counter (OTC) drug markets are mature, valued at approximately $30 billion and $24 billion respectively, it is Asia’s OTC market that is showing the fastest growth. Many countries in Asia are experiencing strong economic growth, and... Read More

img-01

Malaysia’s New Medical Advertising Regulations

Malaysia’s healthcare sector, including pharmaceuticals and medical devices, is one of the country’s largest industries, valued at around $1 billion. Currently, Malaysia has over 250 private medical facilities, and the country’s medical market is growing at an annual rate of 6-7 percent.... Read More